Background. Acromegaly is a rare serious condition characterized by chronic hypersecretion of growth hormone (GH) from a pituitary adenoma and induces the synthesis of insulin-like growth factor I (IGF-1). The idea of the crucial GH importance not only in the control of cell proliferation and differentiation, but, also, in the regulation of immune cells metabolism allows to think that chronic excess GH/IGF-I in acromegaly is the potent effector distortion of the immune response mechanisms. Aim — to study the NAD(P)-dependent dehydrogenases level in blood lymphocytes and their interaction with GH/IGF-1 concentration in patients with active acromegaly. Material and methods. The level of NAD(P)-dependent dehydrogenases in blood lymphocytes was studied in a group of 88 patients with active acromegaly, mean age 51.0±12.5 years. The NAD(P)-dependent dehydrogenases activity was determined by biochemiluminescence method. The concentrations of GH and IGF-1 were measured by ELISA. Results. Studying the activity of mitochondrial NAD(P)-dependent dehydrogenases found a decrease in all NAD-dependent oxidoreductase: NADIDH, NADGDH, and MDH (p<0.01), which allows to state the low level flow in the tricarboxylic acid cycle. In active acromegaly were revealed the decreasing activity of all studied oxidoreductases: glucose-6-phosphate dehydrogenase (p<0.01), NAD–lactate dehydrogenase (LDH) (p<0.001), NADH–LDH (p<0.001), NAD-malate dehydrogenase (MDH) (p<0.001), NADH—MDH (p<0.001), NADP—MDH (p<0.001), NAD-glutamate dehydrogenases (GDH) and NADH—GDH (p<0.001), NADP—GDH and NADPH—GDH (p<0.001), NAD-isocitrate dehydrogenases (IDH) and NADP—IDH (p<0.01 and p<0.001 respectively), and, also, glutathione reductase (p<0.001). Our data observed that decreasing activity of NADP—GDH positively correlated with the basal GH level (r=+0.23; p=0.04) and NADP—MDH activity with IGF-1 level (r=+0.30; p=0.008). The low NADH—MDH activity negatively correlated to the basal GH concentration (r=–0.23; p=0.04). Conclusion. The chronic excess of GH/IGF-1 causes a significant depletion of metabolic lymphocytes reserves and may play an important role in several systems malignancies of acromegaly patients. This pathway continues to attract interest as a potentially useful target for therapeutic design of acromegaly.